Subscribe

Category: Expert Perspectives in Vitiligo

Shanna Miranti, MPAS, PA-C: Prescribing Ruxolitinib for Patients with Vitiligo

Shanna Miranti, MPAS, PA-C, discusses prescribing considerations for topical ruxolitinib in patients with vitiligo, emphasizing the importance of prior treatment attempts with topical corticosteroids and

PLAY
Nada Elbuluk, MD: Psychological Comorbidity Assessment and Counseling for Patients with Vitiligo

Nada Elbuluk, MD, discusses the importance of assessing psychological comorbidities in patients with vitiligo by gathering key social information, including daily activities, living situation, and

PLAY
Shanna Miranti, MPAS, PA-C: Assessing Treatment Efficacy in Patients with Vitiligo
Shanna Miranti, MPAS, PA-C, discusses the similar efficacy seen in patients treated with ruxolitinib at diagnosis versus those who had disease for years.
PLAY
James Del Rosso, DO: Discussing Early Immune Activity Upon Ruxolitinib Cream Withdrawal
Dr. Del Rosso, JCAD’s Clinical Editor-in-Chief, reviews a poster presented by Volkova et al at the 2024 American Academy of Dermatology annual meeting. The poster
PLAY
Shanna Miranti, MPAS, PA-C: Managing the Psychosocial Impact of Vitiligo
Shanna Miranti, MPAS, PA-C, discusses the bimodal distribution of vitiligo in male and female individuals and the necessary counseling for those who are managing their
PLAY
Nada Elbuluk, MD: Connecting Patients with Vitiligo with Supportive Resources
Dr. Elbuluk discusses the importance of connecting patients with vitiligo to supportive resources for preventing and mitigating anxiety and depression related to the condition, especially
PLAY
Andrea Nguyen, PA-C, MS: Determining Treatment Goals and Expectations for Patients with Vitiligo
Andrea Nguyen discusses how she counsels patients with vitiligo and emphasizes the importance in communicating with patients about consistent application and dosing during a treatment
PLAY
Nada Elbuluk, MD: New Research on Psychological Comorbidities in Patients with Vitiligo
Dr. Elbuluk discusses a recently published retrospective chart review that she and her colleagues published in the Archives of Dermatological Research, which included all patients
PLAY
Raj Chovatiya, MD, PhD: Utilizing Ruxolitinib Cream for Patients with Vitiligo
Dr. Chovatiya discusses how to effectively treat patients with nonsegmental vitiligo using topical ruxolitinib cream and the importance in a slow and steady treatment regimen.
PLAY
Nada Elbuluk, MD, FAAD: Research and Utility of Ruxolitinib Cream for Vitiligo
Dr. Elbuluk discusses results of the clinical trials for ruxolitinib cream in patients with vitiligo and how this treatment is being incorporated into the dermatologist’s
PLAY
John Harris, MD, PhD: Effective Treatment for Patients with Vitiligo
John Harris, MD, PhD, Chair of Dermatology at UMass Chan Medical School, discusses the impact topical ruxolitinib cream has had on patients with vitiligo. He
PLAY
Seemal Desai, MD, FAAD: Updated Advancements in Vitiligo Treatment
Seemal Desai, MD, a board-certified dermatologist in private and academic practice in Dallas, Texas, discusses the positive impact a recent topical approval has shown for
PLAY
Susan Taylor, MD: The Impact of Vitiligo on Patients of Color​
Susan Taylor, MD, Professor of Dermatology at The University of Pennsylvania in Philadelphia, Pennsylvania, reviews the burden of vitiligo on patients of color and reviews
PLAY
Nada Elbuluk, MD: Current and Future Treatment Options for Patients with Vitiligo
Nada Elbuluk, MD, a board certified dermatologist at the University of Southern California in Los Angeles, California, discusses the importance of offering a variety of
PLAY
John Harris, MD, PhD: The Evolution of Treatments for Vitiligo
John Harris, MD, PhD, Chair of Dermatology at Umass Chan Medical School, reviews the history of treatments for vitiligo, current treatments for vitiligo and their
PLAY

More JCAD.TV: